Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsReceivablesReceivables - NetRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Addex Therapeutics (ADXN) Long-Term Investments (2022 - 2025)

Historic Long-Term Investments for Addex Therapeutics (ADXN) over the last 4 years, with Q3 2025 value amounting to $8859.3.

  • Addex Therapeutics' Long-Term Investments rose 875.09% to $8859.3 in Q3 2025 from the same period last year, while for Sep 2025 it was $8859.3, marking a year-over-year increase of 875.09%. This contributed to the annual value of $8058.1 for FY2024, which is 8668.28% down from last year.
  • As of Q3 2025, Addex Therapeutics' Long-Term Investments stood at $8859.3, which was up 875.09% from $8559.1 recorded in Q2 2025.
  • Over the past 5 years, Addex Therapeutics' Long-Term Investments peaked at $62748.8 during Q1 2022, and registered a low of $7816.9 during Q2 2024.
  • Its 4-year average for Long-Term Investments is $35681.0, with a median of $56274.0 in 2022.
  • In the last 5 years, Addex Therapeutics' Long-Term Investments plummeted by 8706.82% in 2024 and then soared by 949.56% in 2025.
  • Quarter analysis of 4 years shows Addex Therapeutics' Long-Term Investments stood at $56421.7 in 2022, then rose by 8.58% to $61265.0 in 2023, then tumbled by 86.79% to $8092.2 in 2024, then grew by 9.48% to $8859.3 in 2025.
  • Its last three reported values are $8859.3 in Q3 2025, $8559.1 for Q2 2025, and $7890.3 during Q1 2025.